Sapna Srivastava
CIK: 0001569226
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jul 15, 2026NUVL
Nuvalent, Inc.
Disposition(D)Direct3.4K shares- - Jul 15, 2026NUVL
Nuvalent, Inc.
Tender Offer(U)Direct5.1K shares at avg. $124.00$638K - Jun 30, 2026ALMS
ALUMIS INC.
Award(A)Direct3.6K shares- - Jun 16, 2026NUVL
Nuvalent, Inc.
Award(A)Direct3.4K shares- - Jun 11, 2026AURA
Aura Biosciences, Inc.
Award(A)Direct15K shares- - Oct 28, 2025TRML
Tourmaline Bio, Inc.
Tender Offer(U)Direct518 shares- - Oct 28, 2025TRML
Tourmaline Bio, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
20K shares- - Oct 28, 2025TRML
Tourmaline Bio, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
10K shares- - Oct 28, 2025TRML
Tourmaline Bio, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
16.8K shares- - Jul 30, 2025ALMS
ALUMIS INC.
Award(A)DirectStock Option (Right to Buy)
49.8K shares- - Jun 18, 2025NUVL
Nuvalent, Inc.
Award(A)Direct2.6K shares- - Jun 17, 2025AURA
Aura Biosciences, Inc.
Award(A)Direct13K shares- - Jun 4, 2025TRML
Tourmaline Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
16.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  NUVL Nuvalent, Inc. | Disposition(D) | 3,444 | - | $0 | Direct |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Tender Offer(U) | 5,146 | $124.00 | $638,104 | Direct |
| Jun 30, 2026 |  ALMS ALUMIS INC. | Award(A) | 3,553 | - | $0 | Direct |
| Jun 16, 2026 | NUVL Nuvalent, Inc. | Award(A) | 3,444 | - | $0 | Direct |
| Jun 11, 2026 |  AURA Aura Biosciences, Inc. | Award(A) | 15,000 | - | $0 | Direct |
| Oct 28, 2025 |  TRML Tourmaline Bio, Inc. | Tender Offer(U) | 518 | - | - | Direct |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 16,800 | - | - | Direct |
| Jul 30, 2025 | ALMS ALUMIS INC. | Award(A) Stock Option (Right to Buy) | 49,800 | - | - | Direct |
| Jun 18, 2025 | NUVL Nuvalent, Inc. | Award(A) | 2,647 | - | - | Direct |
| Jun 17, 2025 | AURA Aura Biosciences, Inc. | Award(A) | 13,000 | - | - | Direct |
| Jun 4, 2025 | TRML Tourmaline Bio, Inc. | Award(A) Stock Option (Right to Buy) | 16,800 | - | - | Direct |
1-13 of 13 transactions
About Srivastava Sapna
Srivastava Sapna (SEC CIK 0001569226) files insider reports with the SEC as Director of Nuvalent, Inc. (NUVL), Director of ALUMIS INC. (ALMS) and Director of Aura Biosciences, Inc. (AURA). Signal8 also holds filings tied to 1 other company.
Signal8 holds 9 ownership filings by Srivastava Sapna, all Form 4s, filed between Jun 6, 2025 and Jul 15, 2026. Those filings report 13 transactions, from Jun 4, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Srivastava Sapna's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Srivastava Sapna
- Jul 15, 2026: Disposition to issuer transaction of NUVL shares (Form 4, code D).
- Jul 15, 2026: Tender of shares transaction of NUVL shares (Form 4, code U).
- Jun 30, 2026: Grant or award of ALMS shares (Form 4, code A).
- Jun 16, 2026: Grant or award of NUVL shares (Form 4, code A).
- Jun 11, 2026: Grant or award of AURA shares (Form 4, code A).
Other insiders filing for Nuvalent, Inc. (NUVL)
- Flynn James E, Director
- Meyers Michael L., Director
- Balcom Alexandra, Chief Financial Officer
- Oliger Christy J., Director
- Squarer Ron, Director
- Turner Christopher Durant, Chief Medical Officer